NO302736B1 - Farmasöytisk preparat omfattende tramadol og ibuprofen - Google Patents
Farmasöytisk preparat omfattende tramadol og ibuprofen Download PDFInfo
- Publication number
- NO302736B1 NO302736B1 NO924169A NO924169A NO302736B1 NO 302736 B1 NO302736 B1 NO 302736B1 NO 924169 A NO924169 A NO 924169A NO 924169 A NO924169 A NO 924169A NO 302736 B1 NO302736 B1 NO 302736B1
- Authority
- NO
- Norway
- Prior art keywords
- tramadol
- ibuprofen
- analgesic
- opioid
- compositions
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title claims abstract description 36
- 229960004380 tramadol Drugs 0.000 title claims abstract description 36
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title claims abstract description 36
- 229960001680 ibuprofen Drugs 0.000 title claims description 38
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title claims description 37
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 9
- 239000003814 drug Substances 0.000 claims description 22
- 229940079593 drug Drugs 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 3
- 230000003637 steroidlike Effects 0.000 claims description 3
- 230000002757 inflammatory effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 239000000203 mixture Substances 0.000 abstract description 11
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract description 10
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 6
- 230000000144 pharmacologic effect Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 208000004756 Respiratory Insufficiency Diseases 0.000 abstract description 3
- 206010038678 Respiratory depression Diseases 0.000 abstract description 3
- 230000000294 tussive effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 21
- 230000000202 analgesic effect Effects 0.000 description 14
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 11
- 239000000730 antalgic agent Substances 0.000 description 11
- 229960003107 tramadol hydrochloride Drugs 0.000 description 11
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 10
- 229940121367 non-opioid analgesics Drugs 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 8
- 229940005483 opioid analgesics Drugs 0.000 description 8
- 230000036592 analgesia Effects 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 239000000014 opioid analgesic Substances 0.000 description 7
- 230000003187 abdominal effect Effects 0.000 description 5
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 5
- 229960004373 acetylcholine Drugs 0.000 description 5
- 229940035676 analgesics Drugs 0.000 description 5
- 229960005489 paracetamol Drugs 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 229960001138 acetylsalicylic acid Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- -1 aspirin Chemical compound 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 206010052804 Drug tolerance Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 230000026781 habituation Effects 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960001017 tolmetin Drugs 0.000 description 2
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- UYHNNWQKLGPQQX-UHFFFAOYSA-N 2-[2-(2-methylpropyl)phenyl]propanoic acid Chemical compound CC(C)CC1=CC=CC=C1C(C)C(O)=O UYHNNWQKLGPQQX-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229940127450 Opioid Agonists Drugs 0.000 description 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- ZEHGKSPCAMLJDC-UHFFFAOYSA-M acetylcholine bromide Chemical compound [Br-].CC(=O)OCC[N+](C)(C)C ZEHGKSPCAMLJDC-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- IFKLAQQSCNILHL-QHAWAJNXSA-N butorphanol Chemical compound N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 IFKLAQQSCNILHL-QHAWAJNXSA-N 0.000 description 1
- 229960001113 butorphanol Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960000920 dihydrocodeine Drugs 0.000 description 1
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003402 opiate agonist Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 229960002085 oxycodone Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229960003414 zomepirac Drugs 0.000 description 1
- ZXVNMYWKKDOREA-UHFFFAOYSA-N zomepirac Chemical compound C1=C(CC(O)=O)N(C)C(C(=O)C=2C=CC(Cl)=CC=2)=C1C ZXVNMYWKKDOREA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78513791A | 1991-10-30 | 1991-10-30 | |
| JP4328751A JPH06157301A (ja) | 1991-10-30 | 1992-11-13 | トラマドール物質及び非ステロイド抗炎症薬を含んで成る組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO924169D0 NO924169D0 (no) | 1992-10-29 |
| NO924169L NO924169L (no) | 1993-05-03 |
| NO302736B1 true NO302736B1 (no) | 1998-04-20 |
Family
ID=26572968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924169A NO302736B1 (no) | 1991-10-30 | 1992-10-29 | Farmasöytisk preparat omfattende tramadol og ibuprofen |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0546676B1 (de) |
| JP (1) | JPH06157301A (de) |
| KR (1) | KR100236562B1 (de) |
| CN (1) | CN1072930C (de) |
| AT (1) | ATE285237T1 (de) |
| AU (1) | AU661723B2 (de) |
| CA (1) | CA2081604C (de) |
| DE (1) | DE69233462T2 (de) |
| DK (1) | DK0546676T3 (de) |
| EG (1) | EG20041A (de) |
| ES (1) | ES2235152T3 (de) |
| HU (1) | HUT63557A (de) |
| IL (1) | IL103594A (de) |
| MX (1) | MX9206257A (de) |
| NO (1) | NO302736B1 (de) |
| NZ (1) | NZ244916A (de) |
| PH (1) | PH31378A (de) |
| PT (1) | PT546676E (de) |
| SG (1) | SG55086A1 (de) |
| ZA (1) | ZA928372B (de) |
| ZW (1) | ZW17892A1 (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
| US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
| IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
| US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
| KR100354702B1 (ko) | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
| US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| DE19630035A1 (de) * | 1996-07-25 | 1998-01-29 | Asta Medica Ag | Tramadol Multiple Unit Formulierungen |
| DE19641576C1 (de) * | 1996-10-09 | 1998-05-07 | Gruenenthal Gmbh | Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten |
| DE19712398A1 (de) * | 1997-03-25 | 1998-10-01 | Gruenenthal Gmbh | Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel |
| RS49982B (sr) | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
| JP2002538176A (ja) * | 1999-03-01 | 2002-11-12 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物 |
| DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| US8173164B2 (en) | 1999-06-17 | 2012-05-08 | Gruenenthal Gmbh | Oral administration forms for administering a fixed tramadol and diclofenac combination |
| DE19927688A1 (de) * | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| DE19927689A1 (de) * | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| PT1623703E (pt) | 1999-10-29 | 2012-01-09 | Euro Celtique Sa | Formulações de hidrocodona de libertação controlada |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| EP2283829A1 (de) | 2000-10-30 | 2011-02-16 | Euro-Celtique S.A. | Hydrocodon-Formulierungen mit gesteuerter Freisetzung |
| DE10059020A1 (de) * | 2000-11-28 | 2002-05-29 | Gruenenthal Gmbh | Parenteral applizierbare Darreichungsformen |
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| UA81224C2 (uk) | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| AU2003264311A1 (en) * | 2002-08-28 | 2004-04-08 | Jin Wang | Oral formulations of ibuprofen and tramadol, methods and preparation thereof |
| WO2007105929A1 (es) * | 2006-03-16 | 2007-09-20 | Farmacéuticos Rayere, S.A. | Composición farmacéutica sinergística de tramadol y clonixinato de lisina |
| ES2358763T3 (es) * | 2006-04-28 | 2011-05-13 | Grünenthal GmbH | Combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metilpropil)fenol y un nsaid. |
| BRPI0700133A (pt) * | 2007-01-29 | 2008-09-16 | Incrementha P D & I Pesquisa D | composição farmacêutica compreendendo tramadol e cetoprofeno em combinação |
| MX2007003948A (es) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
| EP2022778A1 (de) * | 2007-08-07 | 2009-02-11 | Laboratorios del Dr. Esteve S.A. | Kristalline Form von (R,R)-Tramadol-(S)-Naproxensalz |
| EP2149546A1 (de) * | 2008-07-31 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | Tramadolsalze und Ibuprofen sowie ihre Kristallform in der Schmerzbehandlung |
| EP2177215A1 (de) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-Kristalle von Tramadol und NSARs |
| CA2750144C (en) | 2008-12-31 | 2016-10-25 | Upsher-Smith Laboratories, Inc. | Opioid-containing oral pharmaceutical compositions and methods |
| EP2266948A1 (de) * | 2009-06-16 | 2010-12-29 | Laboratorios Del. Dr. Esteve, S.A. | Tramadolsalze und Diflunisal sowie ihre Kristallform in der Schmerzbehandlung |
| ES2353541B1 (es) | 2009-07-30 | 2011-09-20 | Farmalider, S.A. | Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion. |
| EP2281558A1 (de) | 2009-08-06 | 2011-02-09 | Laboratorios Del. Dr. Esteve, S.A. | Pharmazeutische Verbindungen von O-Desmethyltramadol und COX-Inhibitoren |
| BR112012008317A2 (pt) | 2009-09-17 | 2016-03-22 | Upsher Smith Lab Inc | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal |
| PL2488169T3 (pl) | 2009-10-16 | 2013-06-28 | Esteve Pharmaceuticals Sa | Kokryształy tramadolu i koksybów |
| CN104817501B (zh) * | 2009-10-16 | 2017-09-22 | 埃斯蒂文博士实验室股份有限公司 | 曲马多与昔布类的共晶体 |
| EP2311446A1 (de) | 2009-10-16 | 2011-04-20 | Laboratorios Del. Dr. Esteve, S.A. | Zusammensetzungen, die Tramadol und Celecoxib umfassen, zur Behandlung von Schmerzen |
| EP2353594A1 (de) | 2010-02-09 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Zusammensetzungen aus Tramadol und dem Co-Kristall von Celecoxib und L-Prolin bei der Schmerzbehandlung |
| US10525054B2 (en) | 2011-11-07 | 2020-01-07 | Inheris Biopharma, Inc. | Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound |
| CN103906522B (zh) * | 2011-11-07 | 2017-04-12 | 尼克塔治疗公司 | 阿片激动剂化合物和止痛化合物的组合物、剂型以及共给药 |
| ES2423866B1 (es) * | 2012-02-22 | 2014-06-10 | Farmalider, S.A. | Composición farmaceútica de ibuprofeno y tramadol para inyección |
| ES2432222B1 (es) * | 2012-04-30 | 2014-06-10 | Farmalider S.A. | Composición farmacéutica inyectable de dexketoprofeno y tramadol |
| ITMI20130210A1 (it) | 2013-02-14 | 2014-08-15 | Menarini Lab | Composizioni farmaceutiche contenenti dexketoprofene e tramadolo |
| ES2540151B1 (es) * | 2013-10-11 | 2016-02-29 | Farmalider S.A. | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
| CA3072054A1 (en) | 2017-09-15 | 2019-03-21 | Crystalgenomics, Inc. | Pharmaceutical composition for treating acute and chronic pain, containing polmacoxib and tramadol |
| CN112007024A (zh) * | 2019-05-28 | 2020-12-01 | 江苏恒瑞医药股份有限公司 | 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途 |
| AU2020309160A1 (en) * | 2019-07-09 | 2022-02-17 | Farmalíder, S.A. | Combination of ibuprofen and tramadol for relieving pain |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
-
1992
- 1992-10-26 AU AU27328/92A patent/AU661723B2/en not_active Expired
- 1992-10-28 CA CA002081604A patent/CA2081604C/en not_active Expired - Lifetime
- 1992-10-28 KR KR1019920019908A patent/KR100236562B1/ko not_active IP Right Cessation
- 1992-10-28 NZ NZ244916A patent/NZ244916A/en not_active IP Right Cessation
- 1992-10-29 ZW ZW17892A patent/ZW17892A1/xx unknown
- 1992-10-29 IL IL103594A patent/IL103594A/xx not_active IP Right Cessation
- 1992-10-29 DE DE69233462T patent/DE69233462T2/de not_active Expired - Lifetime
- 1992-10-29 NO NO924169A patent/NO302736B1/no not_active IP Right Cessation
- 1992-10-29 HU HU9203399A patent/HUT63557A/hu unknown
- 1992-10-29 MX MX9206257A patent/MX9206257A/es unknown
- 1992-10-29 SG SG1996005376A patent/SG55086A1/en unknown
- 1992-10-29 DK DK92309930T patent/DK0546676T3/da active
- 1992-10-29 ZA ZA928372A patent/ZA928372B/xx unknown
- 1992-10-29 EG EG66492A patent/EG20041A/xx active
- 1992-10-29 AT AT92309930T patent/ATE285237T1/de active
- 1992-10-29 PH PH45191A patent/PH31378A/en unknown
- 1992-10-29 EP EP92309930A patent/EP0546676B1/de not_active Expired - Lifetime
- 1992-10-29 ES ES92309930T patent/ES2235152T3/es not_active Expired - Lifetime
- 1992-10-29 PT PT92309930T patent/PT546676E/pt unknown
- 1992-10-30 CN CN92113759A patent/CN1072930C/zh not_active Expired - Lifetime
- 1992-11-13 JP JP4328751A patent/JPH06157301A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR930007450A (ko) | 1993-05-20 |
| EG20041A (en) | 1997-03-27 |
| ZW17892A1 (en) | 1994-06-01 |
| JPH06157301A (ja) | 1994-06-03 |
| CN1072930C (zh) | 2001-10-17 |
| PT546676E (pt) | 2005-03-31 |
| IL103594A (en) | 1997-03-18 |
| DE69233462D1 (de) | 2005-01-27 |
| CN1073095A (zh) | 1993-06-16 |
| ATE285237T1 (de) | 2005-01-15 |
| SG55086A1 (en) | 1998-12-21 |
| DE69233462T2 (de) | 2006-02-16 |
| CA2081604C (en) | 2004-01-27 |
| ES2235152T3 (es) | 2005-07-01 |
| AU2732892A (en) | 1993-05-06 |
| IL103594A0 (en) | 1993-03-15 |
| EP0546676A1 (de) | 1993-06-16 |
| NZ244916A (en) | 1995-04-27 |
| NO924169D0 (no) | 1992-10-29 |
| CA2081604A1 (en) | 1993-05-01 |
| AU661723B2 (en) | 1995-08-03 |
| MX9206257A (es) | 1993-11-01 |
| PH31378A (en) | 1998-10-29 |
| HU9203399D0 (en) | 1993-01-28 |
| NO924169L (no) | 1993-05-03 |
| DK0546676T3 (da) | 2005-03-07 |
| ZA928372B (en) | 1994-04-29 |
| KR100236562B1 (ko) | 2000-03-02 |
| EP0546676B1 (de) | 2004-12-22 |
| HUT63557A (en) | 1993-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO302736B1 (no) | Farmasöytisk preparat omfattende tramadol og ibuprofen | |
| NO300197B1 (no) | Preparater omfattende tramadol og et opioid | |
| EP0019282B1 (de) | Analgetische Mischung von Nalbuphin und Acetaminophen | |
| AU651247B2 (en) | Composition comprising a tramadol material and acetaminophen and its use | |
| US4681897A (en) | Pharmaceutical products providing enhanced analgesia | |
| CA2381797C (en) | Composition comprising a tramadol material and an anticonvulsant drug | |
| US5516803A (en) | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug | |
| US5025019A (en) | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | |
| US4322427A (en) | Analgetic compositions and methods of use | |
| JPS61200912A (ja) | 鎮痛剤組成物 | |
| JP2575569B2 (ja) | 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法 | |
| EP3741369A1 (de) | Synergistische pharmazeutische kombination des aktiven enantiomers s-ketorolac-tromethamin und tramadolchlorhydrat | |
| EP0027991A1 (de) | Verwendung eines Gemisches von Verbindungen zur Linderung von Schmerzen | |
| US4840962A (en) | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | |
| US5739139A (en) | Acetaminophen and dimenhydrinate analgesics | |
| CA1200499A (en) | Synergistic compositions of nalbuphine and non- narcotic analgesic compounds | |
| EP0024690B1 (de) | Analgetische Mischung von Nalbuphin mit Acetylsalicylsäure, deren Derivat oder Salz | |
| EP0013110A1 (de) | Analgetikum | |
| WO2004026291A1 (fr) | Formulations orales d'ibuprofene et de tramadol, methodes de preparation de ces dernieres | |
| WO1997048390A1 (en) | Analgesics combining acetaminophen with meclizine | |
| WO1998058637A1 (en) | Acetaminophen and diphenhydramine analgesics | |
| MXPA00000522A (en) | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |